J Med Microbiol Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fry, S. R.
Right arrow Articles by Mukkur, T. K. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fry, S. R.
Right arrow Articles by Mukkur, T. K. S.
Agricola
Right arrow Articles by Fry, S. R.
Right arrow Articles by Mukkur, T. K. S.
J Med Microbiol 57 (2008), 28-35; DOI: 10.1099/jmm.0.47527-0
© 2008 Society for General Microbiology
ISSN 1473-5644

Parenteral immunization of mice with a genetically inactivated pertussis toxin DNA vaccine induces cell-mediated immunity and protection

Scott R. Fry{dagger}, Austen Y. Chen, Grant Daggard and Trilochan K. S. Mukkur

Department of Biological and Physical Sciences, University of Southern Queensland, Toowoomba 4350, Queensland, Australia

Correspondence
Trilochan K. S. Mukkur
tk_mukkur{at}hotmail.com

Received 23 July 2007
Accepted 13 September 2007

The immunogenicity and protective efficacy of a DNA vaccine encoding a genetically inactivated S1 domain of pertussis toxin was evaluated using a murine respiratory challenge model of Bordetella pertussis infection. It was found that mice immunized via the intramuscular route elicited a purely cell-mediated immune response to the DNA vaccine, with high levels of gamma interferon (IFN-{gamma}) and interleukin (IL)-2 detected in the S1-stimulated splenocyte supernatants and no serum IgG. Despite the lack of an antibody response, the lungs of DNA-immunized mice were cleared of B. pertussis at a significantly faster rate compared with mock-immunized mice following an aerosol challenge. To gauge the true potential of this S1 DNA vaccine, the immune response and protective efficacy of the commercial diphtheria–tetanus–acellular pertussis (DTaP) vaccine were included as the gold standard. Immunization with DTaP elicited a typically strong T-helper (Th)2-polarized immune response with significantly higher titres of serum IgG than in the DNA vaccine group, but a relatively weak Th1 response with low levels of IFN-{gamma} and IL-2 detected in the supernatants of antigen-stimulated splenocytes. DTaP-immunized mice cleared the aerosol challenge more efficiently than DNA-immunized mice, with no detectable pathogen after day 7 post-challenge.

Abbreviations: aP, acellular pertussis; CHO, Chinese hamster ovary; CMI, cell-mediated immunity; ConA, concanavalin A; DTaP, diphtheria–tetanus–acellular pertussis; HRP, horseradish peroxidase; i.d., intradermal; IFN-{gamma}, gamma interferon; IL, interleukin; i.m., intramuscular; IMAC, immobilized metal affinity chromatography; i.n., intranasal; i.p., intraperitoneal; PT, pertussis toxin; s.c., subcutaneous; Th, T-helper; wP, whole-cell pertussis.

{dagger}Present address: Panbio Limited, Brisbane, Queensland, Australia.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2008 Society for General Microbiology.